ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.17 CNY | +0.99% |
|
+2.58% | -23.40% |
| Jun. 27 | Hisun Pharmaceutical's Leukemia Drug Passes Chinese Drug Regulator's Consistency Evaluation | MT |
| Jun. 27 | Hisun Pharmaceutical's Leukemia Drug Gets Marketing Approval | MT |
Evolution of the average Target Price on Zhejiang Hisun Pharmaceutical Co., Ltd.
Price target over the last 5 years
History of analyst recommendation changes
24d.4lE9atBuYlmxlRy3vfSmVNXk3aN43el45FdjnauR9zI.kzh6WbgkBC3a8ynf94HtELCjsfYZr6snsQhU2pmlulyaGHsB4wdPIPniaw~e3b6e9eb7d9aebfad45ca9c97e6573bd
Analysts' Consensus
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
7.17
CNY
Average target price
7
CNY
Spread / Average Target
-2.37%
High Price Target
7
CNY
Spread / Highest target
-2.37%
Low Price Target
7
CNY
Spread / Lowest Target
-2.37%
Consensus detail
Consensus revision (last 18 months)
EPS Revisions
- Stock Market
- Equities
- 600267 Stock
- Consensus Zhejiang Hisun Pharmaceutical Co., Ltd.
